← Open Payments lookup

NICOL MORSBY: Open Payments

NPI 1952813156 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$984 in 20 payments from 14 companies in 2025. Trend: 2023 $395 · 2024 $612 · 2025 $984

Food & beverage: $800Education: $184
CompanyPaymentsAmount
Janssen Biotech, Inc.5$269
E.R. Squibb & Sons, L.L.C.1$124
GlaxoSmithKline, LLC.1$122
Regeneron Healthcare Solutions, Inc.1$122
Gilead Sciences, Inc.2$106
Daiichi Sankyo Inc.2$51
SERVIER PHARMACEUTICALS LLC1$31
AstraZeneca Pharmaceuticals LP1$31
Genentech USA, Inc.1$26
Karyopharm Therapeutics Inc.1$24

Products named: RYBREVANT, BREYANZI, OJJAARA, LIBTAYO, ERLEADA, Trodelvy, Enhertu, Oncaspar.

Industry payments across GA — which companies pay providers there.